Chemical compound MN-18 Legal status Legal status| * CA: Schedule II * DE: NpSG (Industrial and scientific use only) * UK: Class B Identifiers IUPAC name * N-(naphthalen-1-yl)-1-pentyl-1H-indazole-3-carboxamide CAS Number| * 1391484-80-2 Y PubChem CID| * 119058030 ChemSpider| * 29763729 UNII| * GP2N1PG5X2 CompTox Dashboard (EPA)| * DTXSID301010033 Chemical and physical data Formula| C23H23N3O Molar mass| 357.457 g·mol−1 3D model (JSmol)| * Interactive image SMILES * CCCCCn1nc(c2c1cccc2)C(=O)Nc1cccc2c1cccc2 InChI * InChI=1S/C23H23N3O/c1-2-3-8-16-26-21-15-7-6-13-19(21)22(25-26)23(27)24-20-14-9-11-17-10-4-5-12-18(17)20/h4-7,9-15H,2-3,8,16H2,1H3,(H,24,27) * Key:UJKHLVOEXULDRU-UHFFFAOYSA-N MN 18 is an indazole-based synthetic cannabinoid that is an agonist for the cannabinoid receptors, with Ki values of 45.72 nM at CB1 and 11.098 nM at CB2 and EC50 values of 2.028 nM at CB1 and 1.233 nM at CB2,[1] and has been sold online as a designer drug.[2][3] It is the indazole core analogue of NNE1. Given the known metabolic liberation (and presence as an impurity) of amantadine in the related compound APINACA, it is suspected that metabolic hydrolysis of the amide group of MN-18 may release 1-naphthylamine, a known carcinogen. MN-18 metabolism has been described in literature.[4][5] ## Legal status[edit] MN-18 is banned in Sweden.[when?][6] On 15 September 2014 the Turkey government banned the sale of MN-18.[7] ## See also[edit] * 5F-NNE1 * 5F-PB-22 * AM-2201 * BB-22 * FUB-JWH-018 * AB-FUBINACA * ADB-FUBINACA * AMB-FUBINACA * FDU-PB-22 * FUB-144 * FUB-APINACA * FUB-PB-22 * MDMB-FUBICA * MDMB-FUBINACA * PB-22 ## References[edit] 1. ^ Gamage TF, Farquhar CE, Lefever TW, Marusich JA, Kevin RC, McGregor IS, et al. (May 2018). "Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA". The Journal of Pharmacology and Experimental Therapeutics. 365 (2): 437–446. doi:10.1124/jpet.117.246983. PMC 5932312. PMID 29549157. 2. ^ "MN-18". Southern Association of Forensic Scientists. Archived from the original on 23 July 2015. Retrieved 23 July 2015. 3. ^ Uchiyama N, Shimokawa Y, Kikura-Hanajiri R, Demizu Y, Goda Y, Hakamatsuka T (February 2015). "N-OH-EDMA, and a cathinone derivative dimethoxy-α-PHP, newly identified in illegal products". Forensic Toxicology. 33 (2): 244–259. doi:10.1007/s11419-015-0268-7. PMC 4525202. PMID 26257833. 4. ^ Diao X, Carlier J, Zhu M, Huestis MA (November 2017). "Human Hepatocyte Metabolism of Novel Synthetic Cannabinoids MN-18 and Its 5-Fluoro Analog 5F-MN-18". Clinical Chemistry. 63 (11): 1753–1763. doi:10.1373/clinchem.2017.277152. PMID 28821542. 5. ^ Kevin RC, Lefever TW, Snyder RW, Patel PR, Gamage TF, Fennell TR, et al. (January 2018). "Kinetic and metabolic profiles of synthetic cannabinoids NNEI and MN-18". Drug Testing and Analysis. 10 (1): 137–147. doi:10.1002/dta.2262. PMC 5785468. PMID 28834241. 6. ^ "Cannabinoider föreslås bli klassificerade som hälsofarlig vara". Folkhälsomyndigheten. 28 May 2014. Retrieved 23 July 2015. 7. ^ "Turkish Drug Law List". Resmi Gazete. 15 Sep 2014. * v * t * e Cannabinoids Phytocannabinoids (comparison)| | Cannabibutols| * CBB | Cannabichromenes| * CBC * CBCA * CBCA-A * CBCB * CBCBA * CBCP * CBCPA * CBCV * CBCVA * CBCQ Cannabicyclols| * CBL * CBLA * CBLB * CBLP * CBLPA * CBLV * CBLVA Cannabidiols| * CBD * CBDA * CBD-C1 * CBD-C5 * CBDB * CBDBA * CBDD * CBDH * CBDP * CBDPA * CBDM * CBDMA * CBDV * CBDVA * CBDQ Cannabielsoins| * CBE * CBEA * CBEA-A * CBEA-B * CBEB * CBEP * CBEPA * CBEV Cannabigerols| * CBG * CBGA * CBGB * CBGBA * CBGM * CBGAM * CBGP * CBGPA * CBNR * CBNRA * CBNRA-A * CBGV * CBGVA * CBGVA-A * CBGQ Cannabiphorols| * CBP Cannabinols| * CBN * CBNA * CBN-C1 * CBN-C2 * CBN-C4 * CBNM * CBND * CBNDA * CBNP * CBNPA * CBVD * CBVDA Cannabitriols| * CBT * CBTA * CBTB * CBTV * CBTVA * CBTP * CBTPA Cannabivarins| * CBV * CBVA Delta-8-tetrahydrocannabinols| * Delta-8-THC * Delta-8-THCA * Delta-8-THCA-A * Delta-8-THCB * Delta-8-THCP * Delta-8-THCV Delta-9-tetrahydrocannabinols| * Delta-9-THC (THC) * THCA * THCMA * THCA-A * THCA-B * THCBA * THCA-C4 * THCC * THCA-C1 * THCA-A-C1 * THCA-B-C1 * THCB * THCH * THCP * THCPA * THCV * THCVA * THCQ Delta-10-Tetrahydrocannabinols| * Delta-10-THC Miscellaneous cannabinoids| * Δ8-iso-THC * Δ4(8)-iso-THC * 7,8-Dihydrocannabinol * 8,9-Dihydrocannabidiol * CBCF * Cannabicitran * CBF * Cannabiglendol * CBM * CBR * CBRPA * Caryophyllene * DCBF * Alkylamides * Epigallocatechin gallate * Gallocatechol * Hexahydrocannabinol (HHC) * Perrottetinene * Serinolamide A * Yangonin Active metabolites| * 3'-OH-THC * 7-OH-CBD * 8,11-DiOH-THC * 11-COOH-THC * 11-OH-CBN * 11-OH-HHC * 11-OH-Δ8-THC * 11-OH-Δ9-THC Endocannabinoids| * Arachidonoyl ethanolamide (AEA; anandamide) * 2-Arachidonoylglycerol (2-AG) * 2-Arachidonyl glyceryl ether (2-AGE; noladin ether) * 2-Oleoylglycerol (2-OG) * N-Arachidonoyl dopamine (NADA) * N-Arachidonylglycine (NAGly) * 2-Arachidonoyl lysophosphatidylinositol (2-ALPI) * N-Arachidonoyl serotonin (AA-5-HT) * Docosatetraenoylethanolamide (DEA) * Lysophosphatidylinositol (LPI) * Oleamide * Oleoylethanolamide (OEA) * Palmitoylethanolamide (PEA) * RVD-Hpα * Stearoylethanolamide (SEA) * O-Arachidonoyl ethanolamine (O-AEA; virodhamine) Synthetic cannabinoid receptor agonists / neocannabinoids| | Classical cannabinoids (dibenzopyrans)| * 9-OH-HHC * 9-Nor-9β-HHC * A-40174 * A-41988 * A-42574 * Ajulemic acid * AM-087 * AM-411 * AM-855 * AM-905 * AM-906 * AM-919 * AM-926 * AM-938 * AM-2389 * AM-4030 * AM-7438 * AM-11245 * AMG-1 * AMG-3 * AMG-36 * AMG-41 * Delta-3-THC * Delta-4-THC * Delta-7-THC * Delta-10-THC * Dexanabinol (HU-211) * DMHP * Dronabinol * HU-210 * HU-243 * JWH-051 * JWH-056 * JWH-057 * JWH-065 * JWH-091 * JWH-102 * JWH-103 * JWH-124 * JWH-130 * JWH-133 * JWH-138 * JWH-139 * JWH-142 * JWH-143 * JWH-161 * JWH-186 * JWH-187 * JWH-188 * JWH-189 * JWH-190 * JWH-191 * JWH-215 * JWH-216 * JWH-217 * JWH-224 * JWH-225 * JWH-226 * JWH-227 * JWH-229 * JWH-230 * JWH-233 * JWH-247 * JWH-254 * JWH-256 * JWH-277 * JWH-278 * JWH-298 * JWH-299 * JWH-300 * JWH-301 * JWH-310 * JWH-336 * JWH-338 * JWH-339 * JWH-340 * JWH-341 * JWH-349 * JWH-350 * JWH-352 * JWH-353 * JWH-354 * JWH-355 * JWH-356 * JWH-357 * JWH-358 * JWH-359 * JWH-360 * JWH-361 * JWH-362 * KM-233 * L-759,633 * L-759,656 * Levonantradol (CP 50,5561) * Menabitan * Nabazenil * Nabidrox (Canbisol) * Nabilone * Nabitan * Naboctate * O-224 * O-581 * O-774 * O-806 * O-823 * O-1057 * O-1125 * O-1191 * O-1238 * O-2048 * O-2113 * O-2365 * O-2372 * O-2373 * O-2383 * O-2426 * O-2484 * O-2545 * O-2694 * O-2715 * O-2716 * O-3223 * O-3226 * Parahexyl * Pirnabine * SP-111 * THC hemisuccinate * THC-O-acetate * THC-O-phosphate | Non-classical cannabinoids| * Cannabicyclohexanol * Cannabinor * CBD-DMH * CP 47,497 * (C6)-CP 47,497 * (C9)-CP 47,497 * CP 55,244 * CP 55,940 * Delta-6-Cannabidiol * HU-308 * HU-320 * HU-331 * HU-336 * HU-345 * HU-446 * HU-465 * HU-910 * HUF-101 * Nonabine * O-1376 * O-1422 * O-1601 * O-1656 * O-1657 * O-1660 * O-1663 * O-1871 * SPA-229 * Tinabinol Adamantoylindoles| * 5F-AKB-48 * APICA * STS-135 Benzimidazoles| * AZ-11713908 * AZD-1940 * BIM-018 * FUBIMINA * MCHB-1 * PF-03550096 * RQ-00202730 Benzoylindoles| * 1-Butyl-3-(2-methoxybenzoyl)indole * 1-Butyl-3-(4-methoxybenzoyl)indole * 1-Pentyl-3-(2-methoxybenzoyl)indole * AM-630 * AM-679 * AM-694 * AM-1241 * AM-2233 * GW-405,833 (L-768,242) * Pravadoline * RCS-4 * WIN 54,461 Cyclohexylphenols| * CP-47,947 * CP-55,940 Eicosanoids| * AM-883 * AM-1346 * ACEA * ACPA * Methanandamide (AM-356) * O-585 * O-689 * O-1812 * O-1860 * O-1861 Hydrocarbons| * JWH-171 * JWH-176 * JWH-220 Indazole carboxamides| * AB-PINACA * AB-FUBINACA Indazole-3- carboxamides| * 4F-MDMB-BINACA * 4'Cl-CUMYL-PINACA * 4'F-CUMYL-5F-PINACA * 5Cl-APINACA * 5F-ADB * 5F-ADB-PINACA * 5F-AMB * 5F-APINACA * 5F-CUMYL-PINACA * 5F-EDMB-PINACA * 5F-EMB-PINACA * AB-CHMINACA * AB-FUBINACA * AB-FUBINACA 2-fluorobenzyl isomer * AB-PINACA * ADB-BINACA * ADB-CHMINACA * ADB-HEXINACA * ADB-FUBINACA * ADB-PINACA * ADB-4en-PINACA * Adamantyl-THPINACA * ADSB-FUB-187 * AMB-CHMINACA * AMB-FUBINACA * APINACA (AKB48) * APP-FUBINACA * CUMYL-4CN-BINACA * CUMYL-CBMINACA * CUMYL-FUBINACA * CUMYL-NBMINACA * CUMYL-PINACA * CUMYL-THPINACA * CUMYL-TSINACA * EMB-FUBINACA * FUB-APINACA * MDMB-4en-PINACA * MDMB-5Br-INACA * MDMB-FUBINACA * MDMB-CHMINACA * MN-18 * PX-2 * PX-3 Indole-3-carboxamides| * 4'F-CUMYL-5F-PICA * 5F-ADBICA * 5F-EDMB-PICA * 5F-MDMB-PICA * 5F-NNE1 * 5F-PCN * 5F-SDB-006 * AB-FUBICA * AB-PICA * ADBICA * ADB-FUBICA * APICA * BMS-F * CUMYL-BICA * CUMYL-CBMICA * CUMYL-CHMICA * CUMYL-NBMICA * CUMYL-PICA * CUMYL-5F-PICA * FDU-NNE1 * MDMB-CHMICA * MMB-CHMICA * MMB-2201 * MN-25 (UR-12) * NNE1 * PX-1 * Org 28312 * Org 28611 * SDB-006 * STS-135 Indole-3-carboxylates| * 5F-PB-22 * FDU-PB-22 * FUB-PB-22 * QUCHIC (BB-22) * QUPIC (PB-22) * NM-2201 Naphthoylindazoles| * THJ-018 * THJ-2201 Naphthoylindoles| * 5F-JWH-398 * AM-1220 * AM-1221 * AM-1235 * AM-2201 * AM-2232 * CHM-081 * EAM-2201 * FUB-JWH-018 * JWH-004 * JWH-007 * JWH-009 * JWH-011 * JWH-015 * JWH-016 * JWH-018 * JWH-019 * JWH-020 * JWH-042 * JWH-043 * JWH-046 * JWH-047 * JWH-048 * JWH-049 * JWH-050 * JWH-070 * JWH-072 * JWH-073 * JWH-076 * JWH-077 * JWH-079 * JWH-080 * JWH-081 * JWH-082 * JWH-083 * JWH-093 * JWH-094 * JWH-095 * JWH-096 * JWH-097 * JWH-098 * JWH-099 * JWH-100 * JWH-116 * JWH-120 * JWH-122 * JWH-148 * JWH-149 * JWH-151 * JWH-153 * JWH-159 * JWH-160 * JWH-163 * JWH-164 * JWH-165 * JWH-166 * JWH-180 * JWH-181 * JWH-182 * JWH-189 * JWH-193 * JWH-198 * JWH-200 * JWH-210 * JWH-211 * JWH-212 * JWH-213 * JWH-234 * JWH-235 * JWH-236 * JWH-239 * JWH-240 * JWH-241 * JWH-242 * JWH-258 * JWH-259 * JWH-260 * JWH-261 * JWH-262 * JWH-265 * JWH-266 * JWH-267 * JWH-268 * JWH-387 * JWH-398 * JWH-416 * JWH-417 * JWH-422 * JWH-423 * JWH-424 * JWH-425 * MAM-1220 * MAM-2201 * NE-CHMIMO Naphthoylpyrroles| * JWH-030 * JWH-031 * JWH-032 * JWH-033 * JWH-036 * JWH-044 * JWH-045 * JWH-145 * JWH-146 * JWH-147 * JWH-150 * JWH-156 * JWH-243 * JWH-244 * JWH-245 * JWH-246 * JWH-292 * JWH-293 * JWH-307 * JWH-308 * JWH-309 * JWH-346 * JWH-347 * JWH-348 * JWH-363 * JWH-364 * JWH-365 * JWH-366 * JWH-367 * JWH-368 * JWH-369 * JWH-370 * JWH-371 * JWH-372 * JWH-373 Naphthylmethylindenes| * JWH-171 * JWH-176 * JWH-220 Naphthylmethylindoles| * JWH-175 * JWH-184 * JWH-185 * JWH-192 * JWH-194 * JWH-195 * JWH-196 * JWH-197 * JWH-199 Phenylacetylindoles| * Cannabipiperidiethanone * JWH-167 * JWH-201 * JWH-202 * JWH-203 * JWH-204 * JWH-205 * JWH-206 * JWH-207 * JWH-208 * JWH-209 * JWH-237 * JWH-248 * JWH-249 * JWH-250 * JWH-251 * JWH-252 * JWH-253 * JWH-302 * JWH-303 * JWH-304 * JWH-305 * JWH-306 * JWH-311 * JWH-312 * JWH-313 * JWH-314 * JWH-315 * JWH-316 * RCS-8 Pyrazolecarboxamides| * 5F-AB-FUPPYCA * 5F-AMPPPCA * AB-CHFUPYCA Pyrrolobenzoxazines| * WIN 55,212-2 Quinolinyl esters| * PB-22 * 5F-PB-22 Tetramethylcyclo- propanoylindazoles| * FAB-144 Tetramethylcyclo- propanoylindoles| * 5Br-UR-144 * 5Cl-UR-144 * A-796,260 * A-834,735 * FUB-144 * UR-144 * XLR-11 * XLR-12 Tetramethylcyclo- propylindoles| * UR-144 * XLR-11 Others| * 2F-QMPSB * 4-HTMPIPO * 4CN-CUMYL-BUT7AICA * 5F-PY-PICA * 5F-PY-PINACA * 5F-3-pyridinoylindole * 5F-ADB-P7AICA * 5F-CUMYL-P7AICA * 5F-CUMYL-PEGACLONE * A-836,339 * A-955,840 * Abnormal cannabidiol * AB-001 * ADB-FUBIATA * ADB-P7AICA * AM-1248 * AM-1714 * BAY 38-7271 * BAY 59-3074 * BzODZ-EPyr * CB-13 * CB-86 * CBS-0550 * CUMYL-4CN-B7AICA * CUMYL-CB-MEGACLONE * CUMYL-CH-MEGACLONE * CUMYL-PEGACLONE * EG-018 * GSK-554,418A * GW-842,166X * JTE 7-31 * LASSBio-881 * LBP-1 * Leelamine * MDA-7 * MDA-19 * MEPIRAPIM * NESS-040C5 * NMP-7 * O-889 * O-1269 * O-1270 * O-1399 * O-1602 * O-2220 * Olorinab * PF-03550096 * PSB-SB-1202 * PTI-1 * PTI-2 * PTI-3 * QMPSB * S-444,823 * S-777,469 * SER-601 * Tedalinab * URB-447 * VSN-16 * WIN 56,098 Allosteric CBR ligands| * Org 27569 * Org 27759 * Org 29647 * RTI-371 * Pregnenolone Endocannabinoid enhancers (inactivation inhibitors)| * 4-Nonylphenylboronic acid * AM-404 * Arachidonoyl serotonin * Arvanil * BIA 10-2474 * Biochanin A * CAY-10401 * CAY-10429 * Genistein * Guineesine * IDFP * JNJ 1661010 * JNJ-42165279 * JZL184 * JZL195 * Kaempferol * LY-2183240 * MK-4409 * O-1624 * O-2093 * Oleoylethanolamide (OEA) * Olvanil * Palmitoylethanolamide (PEA) * PF-04457845 * PF-622 * PF-750 * PF-3845 * PHOP * URB-447 * URB-597 * URB-602 * URB-754 * VDM-11 Anticannabinoids (antagonists/inverse agonists/antibodies)| * AM-251 * AM-281 * AM-630 * AM-1387 * AM-4113 * AM-6527 * AM-6545 * BML-190 * Brizantin (Бризантин) * CAY-10508 * CB-25 * CB-52 * CB-86 * Dietressa (Диетресса) * Drinabant (AVE1625) * Hemopressin * Ibipinabant (SLV319) * JTE-907 * LH-21 * LY-320,135 * MDA-77 * MJ-15 * MK-9470 * NESS-0327 * NIDA-41020 * O-606 * O-1184 * O-1248 * O-1918 * O-2050 * O-2654 * Otenabant (CP-945,598) * PF-514273 * PipISB * PSB-SB-487 * Rimonabant (SR141716) * Rosonabant (E-6776) * SR-144,528 * Surinabant (SR147778) * Taranabant (MK-0364) * TM-38837 * VCHSR * See also: Cannabinoid receptor modulators (cannabinoids by pharmacology) * List of: AM cannabinoids * JWH cannabinoids * Designer drugs § Synthetic cannabimimetics This cannabinoid related article is a stub. You can help Wikipedia by expanding it. | * v * t * e *[CA]: Canada *[DE]: Germany *[UK]: United Kingdom *[CID]: Compound ID *[EPA]: U.S. Environmental Protection Agency *[v]: View this template *[t]: Discuss this template *[e]: Edit this template *[CBR]: Cannabinoid receptor